Ann WhiteSenior Director of Translational Science at Mestag TherapeuticsSpeaker
Agenda Sessions
FAP Conditional LTBR Agonist Designed To Induce Tertiary Lymphoid Structures (TLS) for the Treatment of Solid Tumors
, 16:45View Session